Ikarian Capital’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-136,059
| Closed | -$95K | – | 127 |
|
|
2023
Q1 | $95K | Hold |
136,059
| – | – | 0.02% | 85 |
|
|
2022
Q4 | $122K | Hold |
136,059
| – | – | 0.03% | 59 |
|
|
2022
Q3 | $815K | Sell |
136,059
-517,389
| -79% | -$3.1M | 0.16% | 40 |
|
|
2022
Q2 | $2.7M | Hold |
653,448
| – | – | 0.49% | 24 |
|
|
2022
Q1 | $2.48M | Buy |
653,448
+24,064
| +4% | +$91.4K | 0.33% | 33 |
|
|
2021
Q4 | $2.83M | Hold |
629,384
| – | – | 0.42% | 31 |
|
|
2021
Q3 | $2.93M | Sell |
629,384
-14,672
| -2% | -$68.4K | 0.21% | 55 |
|
|
2021
Q2 | $4.54M | Sell |
644,056
-32,238
| -5% | -$227K | 0.37% | 36 |
|
|
2021
Q1 | $4M | Buy |
+676,294
| New | +$4M | 0.13% | 56 |
|
|
2020
Q3 | – | Sell |
-328,824
| Closed | -$9.46M | – | 163 |
|
|
2020
Q2 | $9.46M | Buy |
+328,824
| New | +$9.46M | 0.75% | 11 |
|